AngioDynamics logo
AngioDynamics
ANGO | NASDAQ
Chart Builder DCF Calculator
$11.78
-$0.09 (-0.76%)
At close: Nov 16, 2026, 4:00 PM ET
$11.78
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

AngioDynamics Company Profile

Company profile explained

Company Profile

AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.

Key Executives

Name Position
James C. Clemmer Chief Executive Officer, President & Director
Lawrence T. Weiss Senior Vice President, Chief Legal Officer & Corporate Secretary
Stephen A. Trowbridge Executive Vice President & Chief Financial Officer
Benjamin H. Davis Senior Vice President of Business Development & Strategy
Chad T. Campbell Senior Vice President & GM of Oncology and Interventional Devices
Juan Carlos Serna Senior Vice President of Scientific & Clinical Affairs
Kim L. Seabury Senior Vice President of Information Technology
Laura Piccinini Senior Vice President & GM of Cardiovascular and International
Marna I. Bronfen-Moore Senior Vice President of Human Resources
Saleem Cheeks Vice President of Communications
Warren G. Nighan Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain

Latest SEC Filings

Date Type Title
Oct 30, 2026 4 Filing
Oct 08, 2026 10-Q Quarterly Report
Oct 08, 2026 DEFA14A Filing
Oct 08, 2026 DEF 14A Filing
Oct 08, 2026 8-K Current Report
Oct 08, 2026 8-K Current Report
Sep 29, 2026 10-K/A [Amend] Annual Report
Sep 29, 2026 10-K/A [Amend] Annual Report
Jul 31, 2026 4 Filing
Jul 24, 2026 4 Filing
View All SEC Filings ➞
AngioDynamics
AngioDynamics logo
Country United States
IPO Date Jun 1, 2004
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 632
CEO James C. Clemmer

Contact Details

14 Plaza Drive Latham, New York 12110 United States

Stock Details

Ticker Symbol ANGO
Exchange NASDAQ
Fiscal Year June - May
Reporting Currency USD
CIK Code 0001275187
CUSIP Number 03475V101
ISIN Number US03475V1017
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.